|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:1788-1791
© 2003 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Department of Cardiovascular Surgery, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy
Received for publication January 30, 2003; revisions received May 21, 2003; accepted for publication June 18, 2003.
* Address for reprints: Bruno Chiappini, MD, Department of Cardiovascular Surgery, Policlinico S. Orsola-Malpighi, via Massarenti 9-40138, Bologna, Italy
bruno_chiappini{at}hotmail.com
| Abstract |
|---|
|
|
|---|
METHODS: Between April 1995 and June 2002, 40 patients underwent surgery for atrial fibrillation using radiofrequency ablation and cardiac surgery at the Department of Cardiovascular Surgery of the University of Bologna. There were 8 men and 32 women with a mean age of 62 ± 11.6 years (range: 20 to 80 years).
RESULTS: Concomitant surgical procedures were: mitral valve replacement (n = 13), mitral valve replacement plus tricuspid valvuloplasty (n = 11), combined mitral and aortic valve replacement (n = 8), and combined mitral and aortic valve replacement plus tricuspid valvuloplasty (n = 5). Moreover, 1 patient underwent tricuspid valvuloplasty plus atrial septal defect repair, another required aortic valve replacement plus coronary artery bypass graft, and a third underwent aortic valve replacement. After the mean follow-up time of 16.5 ± 2.5 months survival was 92.8% and the overall cumulative rate of sinus rhythm was 88.5%.
CONCLUSIONS: We conclude that the radiofrequency ablation procedure is a safe and effective means of curing atrial fibrillation with negligible technical and time requirements, allowing recovery of the sinus rhythm and atrial function in the great majority of patients with atrial fibrillation who underwent cardiac surgery (88.5% of our study population).
Restoration of the sinus rhythm (SR) with atrioventricular resynchronization may be difficult in patients with lone or chronic AF. The procedure consists of the surgical approach described by James Cox, namely making linear lesions in the right and left atria to prevent the occurrence of multiple reentering circuits. This surgical procedure is extensive and time-consuming and requires great surgical skill. More recently, Haissaguerre and colleagues1 have demonstrated that radiofrequency (RF) ablation is able to confine the origin of paroxysmal AF to the rapidly firing foci in the pulmonary veins. The efficacy of RF ablation in patients with chronic AF undergoing cardiac surgery has been evaluated and the clinical outcome is presented here.
| Methods |
|---|
|
|
|---|
|
|
Follow-up
The mean follow-up time was 15.5 months (range: 2-74 months). Clinical history and 12-lead electrocardiogram (ECG) were taken during each follow-up visit. Sinus rhythm was defined as a supraventricular rhythm with P waves on the standard 12-lead ECG. Six months after surgery, echocardiography was performed, including transmitral and transtricuspid Doppler echocardiography. E and A waves were detected to evaluate the atrial contraction. At least 1 Holter monitoring of rhythm was performed in each patient 6 months after hospital discharge.
Statistical analysis
Continuous variables are expressed as the mean ± SD. Student t test for paired data was used to assess the statistical significance of differences between pre- and postoperative parameters. A P value <.05 was considered significant. The following preoperative variables were considered for any possible relationship with surgical results: AF duration, age, and left atrial diameters. Survival was calculated according to the Kaplan-Meier method.
| Results |
|---|
|
|
|---|
Follow-up
All 40 patients completed at least 6 months of follow-up. The duration of the follow-up ranged from 7 to 22 months (mean 16.5 ± 2.5). Cumulative survival was 92.8%. At the 12-lead ECG, the cumulative rate of SR was 88.5%. Biatrial contraction was documented during transthoracic Doppler echocardiography in 76.5% of the patients. Twenty-nine patients (72.5%) were under treatment with warfarin sodium and 9 patients (22.5%) were undergoing antiarrhythmic therapy (sotalol or amiodarone). We noted a significant improvement of the New York Heart Association (NYHA) functional class after surgery: 20 patients (50%) were in NYHA class I and 20 (50%) in NYHA class II.
| Discussion |
|---|
|
|
|---|
In an attempt to reduce the procedure time and to simplify the surgical technique, modifications of the original maze procedure have been developed,13 including the application of RF energy.14 Heat propagation is based on resistive and passive mechanisms. In the immediate proximity of the probe, tissue is heated to 50°C to 60°C with consequent coagulation and irreversible destruction of cell and collagen structures. Further away from the probe, the resistance offered by tissue decreases exponentially and the heart rate rapidly decreases. Thus, ablation of the peripheral portion of the lesion results from passive heating with the same effect of irreversible damage being reached over a longer period of time. Both resistive and passive heating propagate in all of the directions so that the tissue lesion is similar in depth and width. Once transmurality is achieved, the effects of RF lesions are the same as those of the other major techniques with effective ablation of atrial muscle, an antiarrhythmic effect, and no significant proarrhythmic activity from the scar tissue.15
The treatment of AF by the application of RF ablation in the atria is based on the concept of preventing functional macro-reentrant circuits16 or eliminating anatomically determined circuits.17 All the lesions are made in the endocardium and replace most of the surgical incisions of the previous techniques. The RF ablation procedure requires 15 to 20 minutes of elective cardiac arrest time in contrast to at least 50 to 60 minutes of the Cox maze III procedure.16,18 The importance of interrupting conduction along the coronary sinus to avoid the development of postsurgical atrial flutter has been recognized.19 Therefore, we also performed RF ablation in the isthmus, between the tricuspid valve annulus and the inferior vena cava. In our study, patients had a long duration of AF (61.9 months) and large left atrial dimensions (56.05 ± 6 mm) but we did not find any statistically significant relationship between these preoperative data and the surgical results. Restoration of SR was demonstrated in 88.5% of patients at follow-up.
These data are comparable to the results documented by different groups,20-25 who found restoration of SR between 70% and 98%, depending on patient preoperative characteristics (lone AF, concomitant heart diseases) and the surgical techniques. All our patients had chronic AF; 12.5% of the patients underwent combined mitral and aortic valve replacement plus tricuspid valvuloplasty and 15% (6 patients) of the previous patients were reoperations. Therefore, we believe that RF ablation should also be considered a safe and effective procedure in eliminating AF in patients suffering from a multiple valve disease and in those undergoing a reoperation.
An important aim of restoring SR is to produce the contraction of both atria, restoring an adequate electromechanical synchrony and decreasing the risk of thromboembolism. In our study, biatrial contraction was restored in 76.5% of the patients. Our data are equivalent to the data of other groups, reporting the occurrence of biatrial contraction in 66.7% to 99% of patients depending on the baseline characteristics.26 RF ablation usually prolongs the crossclamp time only of 10 to 15 minutes. This is a significant advantage in older patients with poor ventricular function and/or multiple valve disease, making it possible to enlarge the indications to restore sinus rhythm surgically.
In conclusion, we believe that the use of RF energy is safe and effective and simplifies the Cox maze III procedure in patients undergoing cardiac surgery, by restoring SR and atrial contraction in the majority of patients and also by reducing operating time.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Johansson, B. Houltz, E. Berglin, G. Brandrup-Wognsen, T. Karlsson, and N. Edvardsson Short-term sinus rhythm predicts long-term sinus rhythm and clinical improvement after intraoperative ablation of atrial fibrillation Europace, May 1, 2008; 10(5): 610 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martin-Suarez, B. Claysset, L. Botta, M. Ferlito, D. Pacini, C. Savini, G. Marinelli, and R. DiBartolomeo Surgery for atrial fibrillation with radiofrequency ablation: four years experience Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 71 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Rogers, G. D. Angelini, L. A. Culliford, R. Capoun, and R. Ascione Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome. Ann. Thorac. Surg., May 1, 2006; 81(5): 1676 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Deneke, K. Khargi, K.-M. Muller, B. Lemke, A. Mugge, A. Laczkovics, A. E. Becker, and P. H. Grewe Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation Eur. Heart J., September 1, 2005; 26(17): 1797 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Halkos, J. M. Craver, V. H. Thourani, F. Kerendi, J. D. Puskas, W. A. Cooper, and R. A. Guyton Intraoperative Radiofrequency Ablation for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery Ann. Thorac. Surg., July 1, 2005; 80(1): 210 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zangrillo, G. Crescenzi, G. Landoni, S. Benussi, M. Crivellari, F. Pappalardo, E. Dorigo, C. Pappone, and O. Alfieri The Effect of Concomitant Radiofrequency Ablation and Surgical Technique (Repair Versus Replacement) on Release of Cardiac Biomarkers During Mitral Valve Surgery Anesth. Analg., July 1, 2005; 101(1): 24 - 29. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |